Published online before print December 29, 2003, doi: 10.1161/01.ATV.0000114236.77009.06
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 American Heart Association, Inc.
Vascular Biology |
Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis
From the Cardiovascular Laboratory (J.H., C.-H.Y., H.-S.K., J.-H.C., H.-J.K., K.-K.H.), Clinical Research Institute, Seoul National University Hospital, Korea; and the Department of Internal Medicine (J.H., C.-H.Y., H.-S.K., J.-H.C., H.-J.K., K.-K.H., B.-H.O., M.-M.L., Y.-B.P.), Seoul National University College of Medicine, Seoul, Korea.
Correspondence to Dr Hyo-Soo Kim or Dr Young-Bae Park, Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong Chongno-gu, Seoul 110-744, Korea. E-mail hyosoo{at}snu.ac.kr
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Objective— Endothelial progenitor cells (EPC) in one study group is not the same as EPC in other investigators, suggesting that EPC is not a single type of cell population. In this study, we tried to demonstrate the heterogeneity of EPC.
Methods and Results— We cultured total mononuclear cells from human peripheral blood to get two types of EPC sequentially from the same donors. We called them early EPC and late EPC. Early EPC with spindle shape showed peak growth at 2 to 3 weeks and died at 4 weeks, whereas late EPC with cobblestone shape appeared late at 2 to 3 weeks, showed exponential growth at 4 to 8 weeks, and lived up to 12 weeks. Late EPC was different from early EPC in the expression of VE-cadherin, Flt-1, KDR, and CD45. Late EPC produced more nitric oxide, incorporated more readily into human umbilical vein endothelial cells monolayer, and formed capillary tube better than early EPC. Early EPC secreted angiogenic cytokines (vascular endothelial growth factor, interleukin 8) more so than late EPC during culture in vitro. Both types of EPC showed comparable in vivo vasculogenic capacity.
Conclusions— We found two types of EPC from a source of adult peripheral blood that might have different roles in neovasculogenesis based on the identified differences.
Key Words: stem cells • endothelial progenitor cell • endothelial cell • angiogenesis • cell therapy
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
There was a report about endothelial progenitor cells (EPC) that differentiated from CD34+-enriched mononuclear cells in peripheral blood and participated in vasculogenesis in the animal hindlimb ischemic model.1 This discovery provoked many trials of therapeutic application of EPC in the cardiovascular field.2–5 In these studies, they used EPC that was spindle-shaped, derived from peripheral blood, and cultured for less than 3 weeks. This EPC showed the limited proliferating potential for long-term culture and disappeared 4 to 6 weeks later in in vitro condition.
But there were reports6,7 suggesting the existence of another type of EPC that originated from bone marrow, circulated in peripheral blood, and showed different morphology and proliferation pattern from EPC that Asahara1 reported. In these studies, prolonged incubation of peripheral mononuclear cells in the presence of vascular endothelial growth factor (VEGF) produced the strikingly proliferating cells that formed colonies and had different phenotype from the early spindle-shaped cells. Eventually the cells formed cobblestone monolayer-like human umbilical vein endothelial cells (HUVEC). These cells could be cultured for up to 30 population doublings and had 10-times more rapidly proliferating potential than freshly isolated HUVEC. Lin et al6 suggested that these cells differentiated from bone marrow-derived stem cells by chromosomal analysis of sex-mismatched bone marrow transplant recipients. Recently, further investigation showed that a certain type of cell, the so-called multipotent adult progenitor cell (MAPC), distinguished from other bone marrow-derived mononuclear cells by surface antigens, CD34-, VE-cadherin-, AC133+, and Flk1+, was a possible origin of the circulating endothelial progenitor cells.8
As stated, there were different cells cultured in vitro that could be classified into at least two different types, although the method for culture or source of the cells was not largely different among the investigators. But there was no report that showed two types of cells simultaneously or that compared the vasculogenic potential of the cells in vitro or in vivo. In this study, we succeeded in the culture of two different EPC from one source that appeared sequentially during culture and compared these two types of EPC.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Isolation of Mononuclear Cells
This study was approved by the institutional review board of the Seoul National University Hospital. Peripheral blood (50 mL) was obtained from donors with informed consent. The mononuclear cells were fractionated from other components of peripheral blood by centrifugation on Histopaque 1077 (Sigma, St. Louis, MO) gradients according to manufacturer’s instructions.
Cell Culture
Isolated mononuclear cells were resuspended by EGM-2 BulletKit system (catalog number CC-3162; Clonetics) consisting of endothelial basal medium, 5% fetal bovine serum, hEGF, VEGF, hFGF-B, IGF-1, ascorbic acid, and heparin; 1 x 107 mononuclear cells per well were seeded on 2% gelatin-coated (Sigma, St. Louis, MO) six-well plates and incubated in a 5% CO2 incubator at 37°C. Under daily observation, first media change was performed 
6 days after plating. Thereafter, media were changed every 3 days. Each cluster or colony was followed-up every day.
Growth Curve
Early EPC derived of 1 x 107 mononuclear cells per well were counted under the inverted microscopy from the day of first media change and followed-up for 8 weeks (n=4). Late EPC from 1 x 107 mononuclear cells appeared 2 weeks after plating as colonies that consisted of cells with different morphology from early EPC. These colonies in the midst of early EPC were harvested with selection tube and trypsinization, and 1 x 104 late EPC were replated on a 100-mm plate. Then, these pure late EPC were cultured for 12 weeks (n=4). To compare the growth rate of late EPC to that of the mature endothelial cells on vessel wall, we primarily cultured endothelial cells of gastroepiploic artery (GEAEC) of totally resected human stomach with informed consent; 1 x 104 cells were seeded to gelatin-coated 100-mm plates and counted for 12 weeks (n=4).
Fluorescence-Activated Cell Sorter Analysis
To assess the change of surface antigen of cells, we performed fluorescence-activated cell sorter (FACS) analysis as described previously.9 We used the following primary antibodies: anti-CD31 (DAKO, Denmark), anti-VEGFR-2 (KDR) (Sigma), anti-VE-Cadherin (BD PharMingen, San Diego, CA), and anti-CD45 (DAKO).
Reverse-Transcriptase Polymerase Chain Reaction
To evaluate the gene expression of eNOS, Flt-1, KDR, VE-Cadherin, and vWF, mRNA was extracted using Trizol Reagent (Gibco BRL) according to the manufacturer’s instructions. The first-strand cDNA was synthesized using the reverse transcription system (Promega), amplified by NOVA-Taq DNA polymerase (Genenmed), in a 25-µL reaction mixture. Polymerase chain reaction was performed using a Mini Cycler (MJ research). Please see http://atvb.ahajournals.org for the detailed polymerase chain reaction program and primers.
In Vitro Tube Formation on Matrigel Plate
Matrigel (Becton Dickinson Labware) basement membrane matrix was added to chamber slide. After 1 hour of incubation at room temperature, 2 x 104 cells were added to the chamber slide with 500 µL EGM-2 media. Twelve hours later, four representative fields were taken and the average of the total area of complete tubes formed by cells per unit area was compared by Image-Pro Plus.
In Vivo Vasculogenesis of EPC in Ischemic Limb of Nude Mouse
All procedures were approved by the Experimental Animal Committee of Clinical Research Institute, Seoul National University Hospital, Seoul, Korea. Female athymic nude mice (Jackson Laboratory, Bar Harbor, ME) 8 to 9 weeks old and 17 to 20 g in weight were anesthetized with 160 mg/kg intraperitoneal pentobarbital for operative resection of one femoral artery. Surgery to induce hindlimb ischemia was completed as described.10 To examine the incorporation of EPC in ischemic limb and contribution to neovasculogenesis in vivo, mice were randomized to one of four groups: (1) 5 x 105 DiI-labeled late EPC in EBM medium were administered systemically through intraventricular injection to 12 mice 3 to 6 hours after surgery; (2) 5 x 105 DiI-labeled early EPC was administered to 12 mice; (3) 5 x 105 DiI-labeled GEAEC was administered to 12 mice; and (4) medium as control was used in 11 mice. Laser Doppler perfusion image analyzer (Moor Instrument, Wilmington, DE) was used to record serial blood flow measurements over the course of 3 weeks after operation.9 Effect of cell injection on limb salvage was also compared. Mice in each group were killed 21 days later.
Measurement of Cytokine Concentration of Supernatant
For 3 days, 1 x 106 cells were incubated with EBM-2 medium, and then the supernatant was harvested. Cytokine concentration was measured with ELISA kit (Quantikine for VEGF, SDF-1, and IL-8; R&D systems).
Statistical Analysis
All data are presented as mean±SEM. Intergroup comparisons were performed by paired Student t test or ANOVA. Probability values of P< 0.05 were interpreted to denote statistical significance.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Two Different Types of EPC
The initially seeded cells were round (Figure 1a). After 3 to 5 days, attached cells appeared and appeared to be clusters (Figure 1b and 1c). They were elongated and had a spindle shape similar to that of the EPC that Asahara first reported (Figure 1d and 1e). We called these cells early EPC. Their number increased for 2 weeks. Thereafter, they did not replicate in vitro and gradually disappeared in 4 weeks after plating. We observed another population of cells with different morphology and growth pattern. These appeared in 2 to 4 weeks (Figure 1f) after plating, with more smooth cytoplasmic outline and were firmly attached to the plate (Figure 1g and 1h) and showed cobblestone appearance similar to HUVEC when they were grown (Figure 1i). They rapidly replicated from several cells to a colony, became monolayer with almost full confluence, and showed multiple population doublings without senescence. Both types of EPC took-up DiI-acLDL (Figure Ia and Ic, available online at http://atvb.ahajournals.org) and showed lectin binding affinity (Figure Ib and Id, available online at http://atvb.ahajournals.org).
|
Different Proliferation and Survival Behaviors of Two Types of EPC
The mean age of the donors of peripheral blood was 56.3±5.6 and that of GEAEC was 55.3±6.3. The number of early EPC cultured from 50 mL of peripheral blood was estimated to be 3 x 105±5 x 104 2 weeks after plating. It proliferated up to 5 x 105 cells for 3 weeks and then slowly died out. Ten thousand late EPC were plated at 2 weeks and their number reached up to 1 x 1011±9 x 1010 by 12 weeks (Figure 2). Ten thousand GEAEC were plated in the same way as late EPC, but they proliferated slower than late EPC and became senescent with population doubling. WST-1 assay demonstrated that late EPC proliferated more rapidly than early EPC or GEAEC (Figure IIa, available online at http://atvb.ahajournals.org). In serum starvation condition for assessment of apoptosis resistance, all cells died away slowly, but late EPC was more resistant against apoptosis under serum deprivation than were early EPC or GEAEC (Figure IIb, available online at http://atvb.ahajournals.org).
|
Different Gene Expression Profiles and Response to VEGF Between the Two Types of EPC
Freshly isolated peripheral mononuclear cells expressed Flt-1, e-NOS, and vWF (Figure 3a). On day 10 after plating, the endothelial differentiation of early EPC could be assumed with the additional expression of VE-cadherin and KDR, although weak. Also, the level of Flt-1 expression elevated. These EC-specific gene expressions decreased at 3 weeks after plating. Late EPC, however, exhibited strong expression of all endothelial genes such as VE-cadherin, Flt-1, KDR, and e-NOS vWF at the same level as HUVEC.
|
Peripheral mononuclear cells on day 0 expressed CD31 and CD45 (Figure III, available online at http://atvb.ahajournals.org). The expression of pan-leukocyte maker CD45 gradually decreased from mononuclear cells to late EPC, whereas the expression of endothelial-specific markers, such as KDR and VE-cadherin, gradually increased. CD31, whose expression is shared by monocytes and endothelial cells, showed biphasic pattern; that is, it showed strong expression in mononuclear cells and late EPC, whereas it showed weak expression in early EPC.
Such differences in gene expression profiles lead to the functional differences between the two types of EPC. Nitric oxide formation in response to VEGF was confirmed by DAF-2DA in both types of EPC (Figure IVa, available online at http://atvb.ahajournals.org). We, however, found that late EPC was brighter than early EPC when we compared the intensity of fluorescence (Figure IVb, available online at http://atvb.ahajournals.org). This fact suggests that late EPC have more competent endothelial function producing nitric oxide.
In Vitro Functional Differences Between the Two Types of EPC
Early EPC intervened in the HUVEC monolayer, but more late EPC were incorporated to HUVEC (Figure Va through Vd, available online at http://atvb.ahajournals.org). The number of late EPC incorporated to HUVEC was higher than early that of EPC (396±10/mm2 versus 258±13/ mm2; P<0.001) (Figure Ve, available online at http://atvb.ahajournals.org).
The capillary network formation of each cell alone on Matrigel showed marked difference. Early EPC elongated its cytoplasmic poles and became longer and spindle-shaped but failed to form tube-like structures (Figure 4a). Late EPC made capillary formation on Matrigel successfully (Figure 4b). We demonstrated these data with the complete tube area in unit area for objective comparison in Figure 4c.
|
When co-cultured with HUVEC, which is the method used in other studies, early EPC incorporated into HUVEC and showed complete tube formation, although the formation was weaker than that of late EPC (Figure 4d through 4f).
In Vivo Vasculogenic Potential of the Two Types of EPC
Despite inferior function of early EPC in vitro, vasculogenic potential in vivo was comparable between the two types of EPC. Review of sections retrieved from the ischemic limbs revealed that EPC with red fluorescence incorporated into vessels (Figure VIa and VIb, available online at http://atvb.ahajournals.org).
Serial examinations of hindlimb perfusion by laser Doppler perfusion image analyses were performed on days 3, 7, 14, and 21, and disclosed profound differences among the groups (Figure 5a). Over the subsequent 21 days, substantial blood flow recovery in mice receiving early EPC and late EPC experienced returned perfusion of the ischemic hindlimb to levels that were similar to those recorded in the contralateral nonischemic hindlimb. In contrast, limb perfusion remained markedly depressed in mice receiving culture media or GEAEC.
|
Capillary density was markedly increased in either type of EPC-transplanted mice compared with the control mice (P<0.001) (Figure VII, available online at http://atvb.ahajournals.org).
Enhanced neovasculogenesis in mice undergoing transplantation with EPC led to important biological consequences. Most mice injected with culture media or GEAEC typically had extensive limb necrosis, leading to autoamputation of the ischemic limb (Figure 5c). In contrast, among mice receiving early EPC, limb salvage occurred in 5 of 12 animals and tip necrosis occurred in 3 of 12 mice. Likewise, a preserved limb was observed in 4 of 12 mice treated with late EPC, and tip necrosis occurred in 4 of 12 mice. The difference in outcome between either type of EPC-treated mice and control groups was statistically significant.
Different Roles of the Two EPC in Neovasculogenesis In Vivo and Their Relationship
To explain the difference between in vitro and in vivo results, several cytokines in supernatant of early or late EPC were measured. The concentration of VEGF and IL-8, well-known angiogenic cytokines, were significantly higher in the supernatant of early EPC than in late EPC (Figure 6a). SDF-1 was not elevated in both supernatants.
|
Additionally, to confirm whether late EPC differentiate from early EPC, we stained early EPC with red fluorescence DiI and traced them to find out whether they differentiated into late EPC or mature endothelial cells. We subcultured DiI-labeled early EPC in low cell density and followed-up several clones. Most of the cells died out in 2 weeks, but several colonies of late EPC-like cells appeared with faint DiI dye (Figure 6b and 6c). This finding demonstrated that late EPC-like cells with faint DiI dye derived from an early EPC and demonstrated that they are rapidly proliferating, which is reflected by the faint dye dilution on cell divisions.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
We cultured two different types of EPC from a source of adult peripheral blood and called them early EPC and late EPC according to their time-dependent appearance. They shared some endothelial phenotypes. However, they showed different morphology, proliferation rate, and survival features. They also had different gene expression profiles. Two types of EPC showed functional difference in vitro in the production of nitric oxide in response to VEGF, the tube formation on Matrigel, and the incorporation to HUVEC monolayer in vitro. Despite these in vitro functional differences, both types of EPC similarly contributed to neovasculogenesis in vivo. Compared with the late EPC, such in vivo vasculogenic potency of early EPC despite of poor in vitro function may be because of the stronger secretory function of angiogenic cytokines. We found that early EPC were heterogeneous cell populations that included a few clones that can generate late EPC.
Two Types of EPC
Asahara et al reported EPC in adult peripheral blood.1 Since then, many studies reported EPC in different ways in terms of cell surface markers or culture method.8,11,12 This suggests that there are heterogeneous cells that have been called EPC without clear definition or classification. To see this heterogeneity, we decided not to separate mononuclear cells by surface marker but instead to culture total mononuclear cells. We could confirm the presence of the two types of cell populations that appeared sequentially from one source. One type of cell population is similar to Asahara’s EPC,1,11,12 and we called this early EPC. The other type of cell population, which we called as late EPC, resembles the cells that Lin6 or Reye8 reported.
Murasawa et al recently reported that the constitutive expression of human telomerase reverse transcriptase allowed early EPC differentiate to fully differentiated cells similar to late EPC in our study.13 But we cultured the total mononuclear cells without any genetic modification and developed EPC, which suggests that constitutive human telomerase reverse transcriptase expression would not always be necessary to generate late EPC. Reyes et al8 demonstrated that bone marrow-derived MAPC, which was different from early EPC based on the surface markers and morphology, differentiated to cells that are similar to the late EPC of our study. But they did not mention the differentiation of early EPC.
Differences of Cell Biologic Behaviors Between Two Types of EPC
Early EPC had a short lifespan of 3 to 4 weeks. This is similar to previous studies in which they did not achieve long-term culture of the cells.1,11,12 Late EPC, however, showed long lifespan and rapidly proliferated. This result is compatible with the previous studies.6,7,8 Late EPC were only considered as mature endothelial cells. Our result suggests that late EPC would be different from mature endothelial cells in terms of proliferation rate and cell senescence, which was proven by comparison between late EPC and the GEAEC, although the mean age of the donors was not significantly different. The proliferation rate of late EPC suggested that late EPC might not be just a detached cell from vessel wall but freshly differentiating young cells from adult stem cells.
Differences in Gene Expression Profiles Between Two Types of EPC
Freshly isolated mononuclear cells expressed not only CD45 but also Flt-1, eNOS, vWF, and CD31. So the latter four genes may be loose endothelial cell-specific markers. This pattern of gene expression changed to two different patterns during in vitro culture. Early EPC gradually lost CD45 and CD31 expression and gained low-level expression of KDR and VE-Cadherin. But early EPC lost this low-level expression of KDR and VE-cadherin at 3 weeks and died out. This was consistent with Asahara’s data reported in 1997,1 but there were various gene expression patterns of early EPC insisted on by different research groups. For example, levels of expression of KDR, CD14, and Flt-1 were differently reported by each group.1,9,11,12 This fact suggests that early EPC is a heterogeneous group of cells that differentiate from hemangioblasts to mature cells. In contrast, the gene expression profiles of late EPC and HUVEC were very similar to each other. Late EPC are homogeneous and well differentiated.
Differences in the In Vitro Functions Between Two Types of EPC
VEGF produces nitric oxide in endothelial cells through KDR.14 The different expression level of KDR between the two types might explain the result of the different amount of NO production. Furthermore, it is known that upregulation of KDR expression on the endothelial cells causes an increase in VEGF-mediated tube formation on Matrigel.15 Higher expression level of KDR in late EPC might cause better tube formation by late EPC. VE-cadherin is specifically expressed in adherent junctions of endothelial cells and exerts important functions in cell–cell adhesion.16 Because late EPC had a higher and longer sustained expression level of VE-cadherin, they might incorporate to HUVEC monolayer better than early EPC.
In Vivo Vasculogenic Potential of Two Types of EPC and Their Relationship
As stated, there are many differences between early EPC and late EPC in genetic and functional aspects in vitro, but there was no significant difference in contribution to neovasculogenesis in ischemic limb. Some explanations might be proposed for this discrepancy between in vitro and in vivo function. First, although early EPC may be poor in in vitro functions, they may be good supporters for endothelial cells forming new vessels. Rheman et al recently reported early EPC-like cells.17 These early EPC-like cells secreted angiogenic cytokines such as VEGF, HGF, and G-CSF, which might result in the improved angiogenesis. We also checked IL-8 and VEGF as angiogenic cytokines and got similar results. These cytokines might activate adjacent endothelial cells and enhance angiogenesis. Second, early EPC might not be a homogeneous population. We confirmed that late EPC appeared in the midst of DiI-labeled early EPC in vitro. Thus, we think that early EPC are a heterogeneous group of cells composed of major clones, dying with continuing culture; the other minor clones are able to generate the colonies of late EPC. Thus, some undifferentiated late EPC, even if small in number, could be included in early EPC to participate in neovasculogenesis.
Considering these findings, we propose the different roles of early and late EPC in vasculogenesis; the early EPC contribute to neovasculogenesis mainly by secreting the angiogenic cytokines that help recruit resident mature endothelial cells and induce their proliferation and survival, whereas late EPC enhance neovasculogenesis by providing a sufficient number of endothelial cells based on their high proliferation potency. The different roles played by two types of EPC in vasculogenesis would be an interesting topic for a future study.
In conclusion, we found two types of EPC from a source of human peripheral blood. There have been previous reports about these two types of EPC; however, this is the first report to our knowledge that demonstrated the two types of EPC simultaneously from a source and analyzed their differences. Two types of EPC had different morphology, proliferation rates, and survival behaviors. They also had different gene expression profiles, leading to different function in vitro. Despite such differences in gene expression and in vitro function, they equally contributed to neovasculogenesis in vivo in that early EPC secreted angiogenic cytokines, whereas late EPC supplied a sufficient number of endothelial cells.
|
Acknowledgments |
|---|
Acknowledgments
This study was supported by a grant from the Korea Health 21 R&D project, Ministry of Health & Welfare, Republic of Korea (02-PJ10-PG8-EC01-0026 to Dr Hyo-Soo Kim), a grant from Korea Science & Engineering Foundation (KOSEF) through the Aging and Apoptosis Research Centre at Seoul National University, Seoul, Republic of Korea to Dr Hyo-Soo Kim, and a grant from Stem Cell Research Center, Republic of Korea (M102KL010001-02K1201-01810 to Dr Young-Bae Park).
|
Footnotes |
|---|
J.H. and C.-H.Y. contributed equally to this work.
Received September 25, 2003; accepted November 19, 2003.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Asahara T, Murohara T, Sullivan A, Silver M, vanderZee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964–967.
2. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Med. 1999; 5: 434–438.[CrossRef][Medline] [Order article via Infotrieve]
3. Asahara T, Takahashi T, Masuda H, Kalka C, Chen DH, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999; 18: 3964–3972.[CrossRef][Medline] [Order article via Infotrieve]
4. Moore MAS, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, Rafii S. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann NY Acad Sci. 2001; 938: 36–47.[Medline] [Order article via Infotrieve]
5. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001; 103: 634–637.
6. Lin Y, Weisdorf D, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000; 105: 71–77.[Medline] [Order article via Infotrieve]
7. Shi Q, Rafii S, Wu MHD, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MAS, Storb RF, Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998; 92: 362–367.
8. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marku PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002; 109: 337–346.[CrossRef][Medline] [Order article via Infotrieve]
9. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000; 97: 3422–3427.
10. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. Mouse model of angiogenesis. Am J Pathol. 1998; 152: 1667–1679.[Abstract]
11. Harraz M, Jiao CH, Hanlon HD, Hartley RS, Schatteman GC. CD34(-) blood-derived human endothelial cell progenitors. Stem Cells. 2001; 19: 304–312.[CrossRef][Medline] [Order article via Infotrieve]
12. Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J, Strasser RH, Daniel WG. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel (R) under angiogenic conditions. Cardiovasc Res. 2001; 49: 671–680.
13. Murasawa S, Llevadot J, Silver M, Isner JM, Losordo DW, Asahara T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation. 2002; 106: 1133–1139.
14. He H, Gu XL, Venema VJ, Venema RC, Marrero MB, Caldwell RB. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk-1/KDR activation of c-Src. J Biol Chem. 1999; 274: 25130–25135.
15. Murota SI, Onodera M, Morita I. Regulation of angiogenesis by controlling VEGF receptor. Atherosclerosis V: the Fifth Saratoga Conference. 2000; 902: 208–213.
16. Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, Ruco LP, Dejana E. A novel endothelial-specific membrane protein is a marker of cell to cell contacts. J Cell Biol. 1992; 118: 1511–1522.
17. Rehman J, Li JL, Orschell CM, March KL. Peripheral blood ‘endothelial progenitor cells’ are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003; 107: 1164–1169.
This article has been cited by other articles:
 |
|
 |
|
  H. Fujinaga, C. D. Baker, S. L. Ryan, N. E. Markham, G. J. Seedorf, V. Balasubramaniam, and S. H. Abman Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants Am J Physiol Lung Cell Mol Physiol, December 1, 2009; 297(6): L1160 - L1169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gianella, U. Guerrini, M. Tilenni, L. Sironi, G. Milano, E. Nobili, S. Vaga, M. C. Capogrossi, E. Tremoli, and M. Pesce Magnetic resonance imaging of human endothelial progenitors reveals opposite effects on vascular and muscle regeneration into ischaemic tissues Cardiovasc Res, October 31, 2009; (2009) cvp325v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Piaggio, V. Rosti, M. Corselli, F. Bertolotti, G. Bergamaschi, S. Pozzi, D. Imperiale, B. Chiavarina, E. Bonetti, F. Novara, et al. Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker Blood, October 1, 2009; 114(14): 3127 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-H. Huang, Y.-H. Chen, C.-H. Wang, J.-S. Chen, H.-Y. Tsai, F.-Y. Lin, W.-Y. Lo, T.-C. Wu, M. Sata, J.-W. Chen, et al. Matrix Metalloproteinase-9 Is Essential for Ischemia-Induced Neovascularization by Modulating Bone Marrow-Derived Endothelial Progenitor Cells Arterioscler Thromb Vasc Biol, August 1, 2009; 29(8): 1179 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Krenning, P. Y. W. Dankers, J. W. Drouven, F. Waanders, C. F. M. Franssen, M. J. A. van Luyn, M. C. Harmsen, and E. R. Popa Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1314 - F1322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Di Stefano, C. Cencioni, G. Zaccagnini, A. Magenta, M. C. Capogrossi, and F. Martelli p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose Cardiovasc Res, June 1, 2009; 82(3): 421 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S-T Lee, K. Chu, K-H Jung, H-K Park, D-H Kim, J-J Bahn, J-H Kim, M-J Oh, S. K. Lee, M. Kim, et al. Reduced circulating angiogenic cells in Alzheimer disease Neurology, May 26, 2009; 72(21): 1858 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P Sieveking and M. K. Ng Cell therapies for therapeutic angiogenesis: back to the bench Vascular Medicine, May 1, 2009; 14(2): 153 - 166. [Abstract] [PDF]
|
|
|
|
 |
|
 A. M. Leone, M. Valgimigli, M. B. Giannico, V. Zaccone, M. Perfetti, D. D'Amario, A. G. Rebuzzi, and F. Crea From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells Eur. Heart J., April 2, 2009; 30(8): 890 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Mouquet, F. Cuilleret, S. Susen, K. Sautiere, P. Marboeuf, P. V. Ennezat, E. McFadden, P. Pigny, F. Richard, B. Hennache, et al. Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1 Eur. Heart J., April 1, 2009; 30(7): 840 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Xiao and Q. Xu Caspase-8, a Double-Edged Sword for EPC Functioning Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 444 - 446. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gulati and R. D. Simari Defining the potential for cell therapy for vascular disease using animal models Dis. Model. Mech., March 1, 2009; 2(3-4): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Chade, X. Zhu, R. Lavi, J. D. Krier, S. Pislaru, R. D. Simari, C. Napoli, A. Lerman, and L. O. Lerman Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular Disease Circulation, February 3, 2009; 119(4): 547 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yamahara and H. Itoh Potential use of endothelial progenitor cells for regeneration of the vasculature Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 17 - 27. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Pula, U. Mayr, C. Evans, M. Prokopi, D. S. Vara, X. Yin, Z. Astroulakis, Q. Xiao, J. Hill, Q. Xu, et al. Proteomics Identifies Thymidine Phosphorylase As a Key Regulator of the Angiogenic Potential of Colony-Forming Units and Endothelial Progenitor Cell Cultures Circ. Res., January 2, 2009; 104(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Obi, K. Yamamoto, N. Shimizu, S. Kumagaya, T. Masumura, T. Sokabe, T. Asahara, and J. Ando Fluid shear stress induces arterial differentiation of endothelial progenitor cells J Appl Physiol, January 1, 2009; 106(1): 203 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-S. Maeng, H.-J. Choi, J.-Y. Kwon, Y.-W. Park, K.-S. Choi, J.-K. Min, Y.-H. Kim, P.-G. Suh, K.-S. Kang, M.-H. Won, et al. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLC{beta}2 axis Blood, January 1, 2009; 113(1): 233 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Smadja, I. Bieche, J.-S. Silvestre, S. Germain, A. Cornet, I. Laurendeau, J.-P. Duong-Van-Huyen, J. Emmerich, M. Vidaud, M. Aiach, et al. Bone Morphogenetic Proteins 2 and 4 Are Selectively Expressed by Late Outgrowth Endothelial Progenitor Cells and Promote Neoangiogenesis Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2137 - 2143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ziebart, C.-H. Yoon, T. Trepels, A. Wietelmann, T. Braun, F. Kiessling, S. Stein, M. Grez, C. Ihling, M. Muhly-Reinholz, et al. Sustained Persistence of Transplanted Proangiogenic Cells Contributes to Neovascularization and Cardiac Function After Ischemia Circ. Res., November 21, 2008; 103(11): 1327 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zhu, S. Evans, B. Yan, T. J. Povsic, V. Tapson, P. J. Goldschmidt-Clermont, and C. Dong Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum-Induced Apoptosis in Endothelial Progenitor Cells Circulation, November 18, 2008; 118(21): 2156 - 2165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, Y. Han, W. Pang, C. Li, X. Xie, J. Y.-J. Shyy, and Y. Zhu AMP-Activated Protein Kinase Promotes the Differentiation of Endothelial Progenitor Cells Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1789 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Silva, E.-S. Kim, H. J. Kong, and D. J. Mooney Material-based deployment enhances efficacy of endothelial progenitor cells PNAS, September 23, 2008; 105(38): 14347 - 14352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-K. Han, H.-S. Lee, H.-M. Yang, J. Hur, S.-I. Jun, J.-Y. Kim, C.-H. Cho, G.-Y. Koh, J. M. Peters, K.-W. Park, et al. Peroxisome Proliferator-Activated Receptor-{delta} Agonist Enhances Vasculogenesis by Regulating Endothelial Progenitor Cells Through Genomic and Nongenomic Activations of the Phosphatidylinositol 3-Kinase/Akt Pathway Circulation, September 2, 2008; 118(10): 1021 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Hirschi, D. A. Ingram, and M. C. Yoder Assessing Identity, Phenotype, and Fate of Endothelial Progenitor Cells Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1584 - 1595. [Full Text] [PDF]
|
|
|
|
|
|
T. He, T. Lu, L. V. d'Uscio, C.-F. Lam, H.-C. Lee, and Z. S. Katusic Angiogenic Function of Prostacyclin Biosynthesis in Human Endothelial Progenitor Cells Circ. Res., July 3, 2008; 103(1): 80 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-P. Diller, S. van Eijl, D. O. Okonko, L. S. Howard, O. Ali, T. Thum, S. J. Wort, E. Bedard, J. S. R. Gibbs, J. Bauersachs, et al. Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension Circulation, June 10, 2008; 117(23): 3020 - 3030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Povsic and P. J. Goldschmidt-Clermont Review: Endothelial progenitor cells: markers of vascular reparative capacity Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 199 - 213. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Thill, N. V. Strunnikova, M. J. Berna, N. Gordiyenko, K. Schmid, S. W. Cousins, D. J. S. Thompson, and K. G. Csaky Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2696 - 2708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chu, K.-H. Jung, S.-T. Lee, H.-K. Park, D.-I. Sinn, J.-M. Kim, D.-H. Kim, J.-H. Kim, S.-J. Kim, E.-C. Song, et al. Circulating Endothelial Progenitor Cells as a New Marker of Endothelial Dysfunction or Repair in Acute Stroke * Supplemental Methods Stroke, May 1, 2008; 39(5): 1441 - 1447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Silvestre, Z. Mallat, A. Tedgui, and B. I. Levy Post-ischaemic neovascularization and inflammation Cardiovasc Res, May 1, 2008; 78(2): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. -T. Lee, K. Chu, K. -H. Jung, D. -H. Kim, E. -H. Kim, V. N. Choe, J. -H. Kim, W. -S. Im, L. Kang, J. -E. Park, et al. Decreased number and function of endothelial progenitor cells in patients with migraine Neurology, April 22, 2008; 70(17): 1510 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chen, J. M. Abrahams, L. M. Smith, J. H. McVey, R. I. Lechler, and A. Dorling Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+ vascular progenitors Blood, April 15, 2008; 111(8): 4155 - 4164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. F. Van Craenenbroeck, C. J. Vrints, S. E. Haine, K. Vermeulen, I. Goovaerts, V. F. I. Van Tendeloo, V. Y. Hoymans, and V. M. A. Conraads A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile J Appl Physiol, April 1, 2008; 104(4): 1006 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Bhatwadekar, J. V. Glenn, G. Li, T. M. Curtis, T. A. Gardiner, and A. W. Stitt Advanced Glycation of Fibronectin Impairs Vascular Repair by Endothelial Progenitor Cells: Implications for Vasodegeneration in Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1232 - 1241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Asosingh, M. A. Aldred, A. Vasanji, J. Drazba, J. Sharp, C. Farver, S. A.A. Comhair, W. Xu, L. Licina, L. Huang, et al. Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial Hypertension Am. J. Pathol., March 1, 2008; 172(3): 615 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Shantsila, T. Watson, H.-F. Tse, and G. Y.H. Lip New insights on endothelial progenitor cell subpopulations and their angiogenic properties. J. Am. Coll. Cardiol., February 12, 2008; 51(6): 669 - 671. [Full Text] [PDF]
|
|
|
|
|
|
P. E. Westerweel, K. den Ouden, T. Q. Nguyen, R. Goldschmeding, J. A. Joles, and M. C. Verhaar Amelioration of anti-Thy1-glomerulonephritis by PPAR-{gamma} agonism without increase of endothelial progenitor cell homing Am J Physiol Renal Physiol, February 1, 2008; 294(2): F379 - F384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Suarez, B. R. Shepherd, D. A. Rao, and J. S. Pober Alloimmunity to Human Endothelial Cells Derived from Cord Blood Progenitors J. Immunol., December 1, 2007; 179(11): 7488 - 7496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-Y. Oh, C.-H. Yoon, J. Hur, J.-H. Kim, T.-Y. Kim, C.-S. Lee, K.-W. Park, I.-H. Chae, B.-H. Oh, Y.-B. Park, et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle Blood, December 1, 2007; 110(12): 3891 - 3899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kanayasu-Toyoda, A. Ishii-Watabe, T. Suzuki, T. Oshizawa, and T. Yamaguchi A New Role of Thrombopoietin Enhancing ex Vivo Expansion of Endothelial Precursor Cells Derived from AC133-positive Cells J. Biol. Chem., November 16, 2007; 282(46): 33507 - 33514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Farha, K. Asosingh, D. Laskowski, L. Licina, H. Sekigushi, D. W. Losordo, R. A. Dweik, H. P. Wiedemann, and S. C. Erzurum Pulmonary gas transfer related to markers of angiogenesis during the menstrual cycle J Appl Physiol, November 1, 2007; 103(5): 1789 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hur, H.-M. Yang, C.-H. Yoon, C.-S. Lee, K.-W. Park, J.-H. Kim, T.-Y. Kim, J.-Y. Kim, H.-J. Kang, I.-H. Chae, et al. Identification of a Novel Role of T Cells in Postnatal Vasculogenesis: Characterization of Endothelial Progenitor Cell Colonies Circulation, October 9, 2007; 116(15): 1671 - 1682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nagano, T. Yamashita, H. Hamada, K. Ohneda, K.-i. Kimura, T. Nakagawa, M. Shibuya, H. Yoshikawa, and O. Ohneda Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood Blood, July 1, 2007; 110(1): 151 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Chen, S.-J. Lin, F.-Y. Lin, T.-C. Wu, C.-R. Tsao, P.-H. Huang, P.-L. Liu, Y.-L. Chen, and J.-W. Chen High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide-Related but Not Oxidative Stress-Mediated Mechanisms Diabetes, June 1, 2007; 56(6): 1559 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-K. Oh, J.-M. Ha, E. O, B. H. Lee, S. K. Lee, B.-S. Shim, Y.-K. Hong, and Y. A. Joe Tumor Angiogenesis Promoted by Ex vivo Differentiated Endothelial Progenitor Cells Is Effectively Inhibited by an Angiogenesis Inhibitor, TK1-2 Cancer Res., May 15, 2007; 67(10): 4851 - 4859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. R. Santhanam, L. A. Smith, T. He, K. A. Nath, and Z. S. Katusic Endothelial Progenitor Cells Stimulate Cerebrovascular Production of Prostacyclin By Paracrine Activation of Cyclooxygenase-2 Circ. Res., May 11, 2007; 100(9): 1379 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Caballero, N. Sengupta, A. Afzal, K.-H. Chang, S. Li Calzi, D. L. Guberski, T. S. Kern, and M. B. Grant Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells Diabetes, April 1, 2007; 56(4): 960 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Murphy, G. S. Kanaganayagam, B. Jiang, P. J. Chowienczyk, R. Zbinden, M. Saha, S. Rahman, A. M. Shah, M. S. Marber, and M. T. Kearney Vascular Dysfunction and Reduced Circulating Endothelial Progenitor Cells in Young Healthy UK South Asian Men Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 936 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Casamassimi, M. L. Balestrieri, C. Fiorito, C. Schiano, C. Maione, R. Rossiello, V. Grimaldi, V. Del Giudice, C. Balestrieri, B. Farzati, et al. Comparison Between Total Endothelial Progenitor Cell Isolation Versus Enriched Cd133+ Culture J. Biochem., April 1, 2007; 141(4): 503 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Shepherd, B. J. Capoccia, S. M. Devine, J. DiPersio, K. M. Trinkaus, D. Ingram, and D. C. Link Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100 Blood, December 1, 2006; 108(12): 3662 - 3667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Dawn and R. Bolli Increasing Evidence That Estrogen Is an Important Modulator of Bone Marrow-Mediated Cardiac Repair After Acute Infarction Circulation, November 21, 2006; 114(21): 2203 - 2205. [Full Text] [PDF]
|
|
|
|
|
|
H. Guven, R. M. Shepherd, R. G. Bach, B. J. Capoccia, and D. C. Link The Number of Endothelial Progenitor Cell Colonies in the Blood Is Increased in Patients With Angiographically Significant Coronary Artery Disease J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1579 - 1587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Fadini, S. Sartore, M. Albiero, I. Baesso, E. Murphy, M. Menegolo, F. Grego, S. Vigili de Kreutzenberg, A. Tiengo, C. Agostini, et al. Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2140 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wu, J. E. Ip, J. Huang, L. Zhang, K. Matsushita, C.-C. Liew, R. E. Pratt, and V. J. Dzau Essential Role of ICAM-1/CD18 in Mediating EPC Recruitment, Angiogenesis, and Repair to the Infarcted Myocardium Circ. Res., August 4, 2006; 99(3): 315 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Cho, T.-Y. Kim, H.-J. Cho, K.-W. Park, S.-Y. Zhang, J.-H. Kim, S.-H. Kim, J.-Y. Hahn, H.-J. Kang, Y.-B. Park, et al. The Effect of Stem Cell Mobilization by Granulocyte-Colony Stimulating Factor on Neointimal Hyperplasia and Endothelial Healing After Vascular Injury With Bare-Metal Versus Paclitaxel-Eluting Stents J. Am. Coll. Cardiol., July 18, 2006; 48(2): 366 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Yoon, J. Hur, I.-Y. Oh, K.-W. Park, T.-Y. Kim, J.-H. Shin, J.-H. Kim, C.-S. Lee, J.-K. Chung, Y.-B. Park, et al. Intercellular Adhesion Molecule-1 Is Upregulated in Ischemic Muscle, Which Mediates Trafficking of Endothelial Progenitor Cells Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1066 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yamada and N. Takakura Physiological pathway of differentiation of hematopoietic stem cell population into mural cells J. Exp. Med., April 17, 2006; 203(4): 1055 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Smadja, I. Bieche, G. Uzan, H. Bompais, L. Muller, C. Boisson-Vidal, M. Vidaud, M. Aiach, and P. Gaussem PAR-1 Activation on Human Late Endothelial Progenitor Cells Enhances Angiogenesis In Vitro With Upregulation of the SDF-1/CXCR4 System Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2321 - 2327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Yoon, J. Hur, K.-W. Park, J.-H. Kim, C.-S. Lee, I.-Y. Oh, T.-Y. Kim, H.-J. Cho, H.-J. Kang, I.-H. Chae, et al. Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Outgrowth Endothelial Cells: The Role of Angiogenic Cytokines and Matrix Metalloproteinases Circulation, September 13, 2005; 112(11): 1618 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Rookmaaker, M. C. Verhaar, C. J.M. Loomans, R. Verloop, E. Peters, P. E. Westerweel, T. Murohara, F. J.T. Staal, A. J. van Zonneveld, P. Koolwijk, et al. CD34+ Cells Home, Proliferate, and Participate in Capillary Formation, and in Combination With CD34- Cells Enhance Tube Formation in a 3-Dimensional Matrix Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1843 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. He, T. E. Peterson, and Z. S. Katusic Paracrine mitogenic effect of human endothelial progenitor cells: role of interleukin-8 Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H968 - H972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Cho, S.-W. Youn, S.-I. Cheon, T.-Y. Kim, J. Hur, S.-Y. Zhang, S. P. Lee, K.-W. Park, M.-M. Lee, Y.-S. Choi, et al. Regulation of Endothelial Cell and Endothelial Progenitor Cell Survival and Vasculogenesis by Integrin-Linked Kinase Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1154 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Ingram, L. E. Mead, D. B. Moore, W. Woodard, A. Fenoglio, and M. C. Yoder Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells Blood, April 1, 2005; 105(7): 2783 - 2786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Choi, J. Hur, C.-H. Yoon, J.-H. Kim, C.-S. Lee, S.-W. Youn, I.-Y. Oh, C. Skurk, T. Murohara, Y.-B. Park, et al. Augmentation of Therapeutic Angiogenesis Using Genetically Modified Human Endothelial Progenitor Cells with Altered Glycogen Synthase Kinase-3{beta} Activity J. Biol. Chem., November 19, 2004; 279(47): 49430 - 49438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Ingram, L. E. Mead, H. Tanaka, V. Meade, A. Fenoglio, K. Mortell, K. Pollok, M. J. Ferkowicz, D. Gilley, and M. C. Yoder Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood Blood, November 1, 2004; 104(9): 2752 - 2760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Biancone, V. Cantaluppi, D. Duo, M. C. Deregibus, C. Torre, and G. Camussi Role of L-Selectin in the Vascular Homing of Peripheral Blood-Derived Endothelial Progenitor Cells J. Immunol., October 15, 2004; 173(8): 5268 - 5274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. He, L. A. Smith, S. Harrington, K. A. Nath, N. M. Caplice, and Z. S. Katusic Transplantation of Circulating Endothelial Progenitor Cells Restores Endothelial Function of Denuded Rabbit Carotid Arteries Stroke, October 1, 2004; 35(10): 2378 - 2384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Urbich and S. Dimmeler Endothelial Progenitor Cells: Characterization and Role in Vascular Biology Circ. Res., August 20, 2004; 95(4): 343 - 353. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||